|
Cardiology
Long-term effects of the mean hemoglobin A1c levels after percutaneous coronary intervention in patients with diabetes
Jaekyung Bae, Ji-Hyung Yoon, Jung-Hee Lee, Jong-Ho Nam, Chan-Hee Lee, Jang-Won Son, Ung Kim, Jong-Seon Park, Dong-Gu Shin
Korean J Intern Med. 2021;36(6):1365-1376. Published online October 14, 2021
Background/Aims: The clinical benefit of strict blood glucose-lowering therapy for patients with coronary artery disease (CAD) is still debated. We aimed to evaluate the long-term outcomes of patients with diabetes who underwent percutaneous coronary intervention (PCI), according to the mean hemoglo..
|
|
|
Five-year clinical outcomes of drug-eluting stents according to on-label and off-label use
Kyu-Hwan Park, Ung Kim, Chan-Hee Lee, Jang-Won Son, Jong-Seon Park, Dong-Gu Shin, Young-Jo Kim, Jeong-Hwan Cho
Korean J Intern Med. 2016;31(4):678-684. Published online March 25, 2016
Background/Aims: To compare the clinical outcomes of ‘on-label’ and ‘off-label’ drug-eluting stents (DESs) over a 5-year follow-up period.
Methods: A total of 929 patients that underwent percutaneous coronary intervention with DESs were enrolled. Patients were divided into two groups according..
|
|
|
Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents
Jang-Won Son, Ung Kim, Jong-Seon Park, Young-Jo Kim, Jae-Sik Jang, Tae-Hyun Yang, Dong-Soo Kim, Dong-Kie Kim, Sang-Hoon Seol, Doo-Il Kim, Chang-Wook Nam, Seung-Ho Hur, Kwon-Bae Kim
Korean J Intern Med. 2013;28(1):72-80. Published online December 28, 2012
Background/AimsThe Taxus Liberte stent (Boston Scientific Co.) evolved from the Taxus Express stent, with enhanced stent deliverability and uniform drug delivery. This study was designed to compare angiographic and clinical outcomes in real-world practice between the Taxus Lib..
|
|
|
